Five Hemlibra Deaths But Not Caused By Hemophilia Drug – Roche

News of the deaths, which included patients using Hemlibra for compassionate use and in clinical trials, has put the drug's safety profile in the spotlight again even though Roche has pointed out investigators have stated that the causes of death were unrelated to the recently-approved hemophilia A therapy.

Blood drops
Hemlibra deaths highlight hemophilia A challenges • Source: Shutterstock

Roche has confirmed that five patients taking its hemophilia therapy Hemlibra (emicizumab) have died, but has stressed to Pink Sheet that in all the cases the treating physician or investigator’s assessment was that the cause of death was unrelated to the Swiss major's potential blockbuster.

News of the deaths emerged after announcements from two patient advocacy groups in the US – the National Hemophilia Foundation...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Drug Safety

More from Pink Sheet